Related Experiment Videos
Clinical characterisation of severe hypoglycaemia--a prospective population-based study
A Holstein1, A Plaschke, E-H Egberts
11st Department of Medicine, Klinikum Lippe-Detmold, Detmold, Germany. andreas.holstein@t-online.de
Summary
Severe hypoglycaemia (SH) risk increases in elderly, multimorbid type 2 diabetes patients, nearing that of type 1 diabetes. Critical treatment targets and awareness are key for geriatric patients to prevent SH.
Area of Science:
- Endocrinology
- Diabetes Mellitus
- Public Health
Background:
- Severe hypoglycaemia (SH) is a critical complication of diabetes management.
- Understanding SH's clinical characteristics in a general population is vital for targeted prevention strategies.
Purpose of the Study:
- To determine the clinical characteristics of severe hypoglycaemia (SH) in a nonselected German population.
- SH was defined as an event requiring intravenous glucose or glucagon injection.
Main Methods:
- A prospective, population-based study was conducted in a region of 200,000 inhabitants from 1997 to 2000.
- Emergency department and emergency medical service patients underwent blood glucose testing to detect SH.
Main Results:
- 264 SH cases were registered, predominantly in type 2 diabetes (56%) and type 1 diabetes (35%).
- The annual SH rate was higher in insulin-treated type 2 diabetics (1.5/100 patients) versus all type 2 diabetics (0.4/100 patients).
- In type 2 diabetes, SH was linked to advanced age, multimorbidity (especially renal impairment), and polypharmacy; 34% resided in nursing homes or received home care.
Conclusions:
- Elderly, multimorbid type 2 diabetes patients face a significantly increased risk of SH, approaching that of type 1 diabetes patients.
- Treatment targets in geriatric patients should be critically evaluated, considering quality of life and life expectancy.
- Impaired awareness of hypoglycaemia is a major risk factor for SH in type 1 diabetes.